GoodRx Holdings (GDRX) Research Hub

GoodRx Holdings (GDRX) trades on NASDAQ, US in the Healthcare (Medical - Healthcare Information Services) sector. As of 2026-09-11, shares last closed at 3.39 USD (+1.50%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 50.00, market cap 1.02B. This hub links to the full technical, earnings and options research available for GDRX.

Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Medical - Healthcare Information Services)
ExchangeNASDAQ, US
Last close3.39 USD (+1.50%)
52-week range2.57 USD – 3.89 USD
Trend regimeRange
14-day RSI38.4 (Bearish)
Trailing P/E50.00
Market cap1.02B
Dividend yield0.00%

Available research for GDRX

Earnings

GDRX earnings: real EPS beat/miss history, analyst consensus Hold, P/E 50.00. Updated 2026-07-23.

Options: Covered Call

Covered Call on GDRX: how it works, illustrative setup around the real 3.39 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on GDRX: how it works, illustrative setup around the real 3.39 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on GDRX: how it works, illustrative setup around the real 3.39 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

GDRX technical analysis: range, last 3.39 USD, RSI 38.4, 52w range 2.57 USD–3.89 USD, real support/resistance. Updated 2026-09-11.

Frequently asked questions

What sector is GDRX in?

GoodRx Holdings (GDRX) is classified under Healthcare (Medical - Healthcare Information Services), listed on NASDAQ, US.

Is GDRX in an uptrend or downtrend?

As of 2026-09-11, GDRX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is GDRX's trailing P/E ratio?

GDRX's trailing P/E is 50.00, with a market cap of 1.02B. See the earnings research page for full valuation detail.